Variability of high-sensitivity cardiac troponin T and I in asymptomatic patients receiving hemodialysis

被引:0
作者
Wanwarang Wongcharoen
Teetad Chombandit
Arintaya Phrommintikul
Kajohnsak Noppakun
机构
[1] Chiang Mai University,Division of Cardiology, Department of Internal Medicine, Faculty of Medicine
[2] Chiang Mai University,Division of Nephrology, Department of Internal Medicine, Faculty of Medicine
[3] Chiang Mai University,Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Variation of high-sensitivity cardiac troponin I and T (hs-cTn) during hemodialysis has been observed. Observational studies demonstrated the increased incidence of adverse cardiovascular events after long compared to short interdialytic intervals. Therefore, we aimed to compare variation of hs-cTnI and hs-cTnT before and after hemodialysis and between short and long interdialytic intervals. We enrolled 200 asymptomatic patients receiving regular hemodialysis. The hs-cTnI and hs-cTnT levels were measured before and after hemodialysis on the day after short and long interdialytic intervals. Mean age was 62.3 ± 14.8 years (Male 55.5%). Prevalence of increased hs-cTnI and hs-cTnT was 34.5% and 99.0%, respectively. The median ± interquartile range of hs-cTnT increased significantly after hemodialysis during short and long interdialytic intervals. However, hs-cTnI level did not increase after hemodialysis during short and long intervals. We found that levels of hs-cTnI and T did not differ between short interdialytic and long interdialytic intervals. We demonstrated higher prevalence of elevated hs-cTnT in patients with regular hemodialysis compared to hs-cTnI. The rise of hs-cTnT was observed immediately after hemodialysis but no significant change of hs-cTnI was noted. Accordingly, hs-cTnI may be preferable as a diagnostic marker in patients with suspected acute myocardial infarction than hs-cTnT.
引用
收藏
相关论文
共 69 条
[1]  
Saran R(2020)US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States Am J Kidney Dis 75 A6-A7
[2]  
Cheung AK(2004)Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study Kidney Int 65 2380-2389
[3]  
Roffi M(2016)2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Eur Heart J 37 267-315
[4]  
Thygesen K(2018)Fourth Universal Definition of Myocardial Infarction (2018) Circulation 138 e618-e651
[5]  
Tarapan T(2019)High sensitivity Troponin-I levels in asymptomatic hemodialysis patients Ren Fail 41 393-400
[6]  
Badiou S(2016)Monthly reference change value of cardiac troponin in hemodialysis patients as a useful tool for long-term cardiovascular management Clin Biochem 49 1195-1198
[7]  
Kalaji FR(2012)Predictive value of cardiac troponin T and I in hemodialysis patients Saudi J Kidney Dis Transpl 23 939-945
[8]  
Albitar S(2014)Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls Clin Chem 60 838-847
[9]  
Aakre KM(2017)Effect of hemodialysis on levels of high-sensitivity cardiac troponin T Am J Cardiol 120 2061-2064
[10]  
Chen M(2016)The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients Scand J Clin Lab Invest 76 645-652